Zero tolerance for complacency by government of West African countries in the face of COVID-19

Author:

Erhabor O.1,Erhabor T.2,Adias T.C.3,Okara G.C.4,Retsky M.5

Affiliation:

1. Department of Haematology, SMLS, Usmanu Danfodiyo University, Sokoto, Nigeria

2. Medical Laboratory Science Council of Nigeria, Nigeria

3. Federal University Otuoke Bayelsa State, Nigeria

4. West African Postgraduate College of Medical Laboratory Science, Nigeria

5. Harvard School of Public Health, Boston, MA, USA

Abstract

A novel Coronavirus (SARS-CoV-2) causing a cluster of respiratory infections (Coronavirus Disease 2019, COVID-19) first discovered in Wuhan, China, is responsible for a new illness that has been found to affect the lungs and airways of patients with associated symptoms of fever, cough and shortness of breath. In the light of few cases recorded so far in West Africa there is tendency for complacency. The region needs to make strategic plans based on available evidence to enable them effectively deal with this rapidly evolving pandemic. At this very moment countries like China, Italy, France, Spain, Iran, UK and many others are witnessing sustained and intensive community transmission of this virus and increasing numbers of severe disease and death particularly among elderly patients with other comorbidities. The reality of the seriousness of this pandemic is alarming. Government of member states of ECOWAS need to prepare themselves by building capacity as well as implement evidenced-based steps to mitigate this rapidly evolving pandemic by testing persons presenting with symptoms (fever, cough and shortness of breath), isolating and treating those found positive, tracing and quarantining contacts, implementing social distancing as well as optimizing human and material endowment to allow healthcare workers offer safe quality clinical care for affected patients to prevent secondary infection among healthcare workers.

Publisher

IOS Press

Subject

General Medicine,Immunology,Immunology and Allergy

Reference59 articles.

1. Global trends in emerging infectious diseases;Jones;Nature,2008

2. A novel coronavirus from patients with pneumonia in China;Zhu;New England Journal of Medicine,2020

3. The International Committee for Taxonomy of Viruses named the causative virus SARS-CoV-2 on 7 Feb 2020.

4. Coronavirus Disease 2019 (COVID-19). Centers for Disease Control and Prevention (CDC). 15 February 2020. Archived from the original on 26 February 2020. Retrieved 20 February 2020.

5. Statement on the second meeting of the International Health Regulations (2005)Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV), World Health Organization (WHO). Archived from the original on 31 January 2020. Retrieved 11 February 2020

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. China's community-based crisis management model for COVID-19: A zero-tolerance approach;Frontiers in Public Health;2022-07-22

2. Health equity: An Islamic view;Health Monitor Journal of the Iranian Institute for Health Sciences Research;2022-04-01

3. The peak of corona virus in Sistan and Baluchestan: A commentry;Health Monitor Journal of the Iranian Institute for Health Sciences Research;2022-02-01

4. Perceptions, experiences and opportunities for occupational safety and health professionals arising out of the COVID-19 Pandemic;Humanities and Social Sciences Communications;2021-11-16

5. Onslaught of COVID-19: How Did Governments React and at What Point of the Crisis?;Population Health Management;2021-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3